Argenx
ARGX
#545
Rank
HK$282.55 B
Marketcap
HK$4,628
Share price
1.47%
Change (1 day)
64.87%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): HK$0.65 Billion

According to Argenx 's latest financial reports the company's current earnings are HK$2.19 Billion. , an increase over its 2023 earnings that were of -HK$2.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 HK$0.66 B-127.97%
2023 -HK$2.37 Billion-58.25%
2022 -HK$5.67 Billion
2019 -HK$1.55 Billion124.95%
2018 -HK$0.69 Billion132.04%
2017 -HK$0.3 Billion54.86%
2016 -HK$0.2 Billion33%
2015 -HK$0.15 Billion13.63%
2014 -HK$0.13 Billion46.25%
2013 -HK$86.49 Million